We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Shortwave Life Sciences Plc | AQSE:PSY | Aquis Stock Exchange | Ordinary Share | GB00BL6CJQ54 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.30 | 0.10 | 0.40 | 0.30 | 0.25 | 0.30 | 0.00 | 16:29:58 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jan 2023 to Jan 2025
TIDMPSY
RNS Number : 2769V
Psych Capital PLC
30 November 2023
30 November 2023
PSYCH CAPITAL PLC
("Psych", "Psych Capital", or "the Company")
Total Voting Rights
In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, Psych Capital hereby announces that the Company has 361,203,467 ordinary shares of GBP0.001 each ("Ordinary Shares") in issue, each share carrying the right to one vote.
The above figure of 361,203,467 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
The directors of the Company accept responsibility for the contents of this announcement.
Enquiries:
Hot Features
Premium
Company
William Potts +44 20 3838 7621
info@psych.capital
https://psych.capital
Peterhouse Capital Limited
Corporate Adviser + 44 0 20 7469
Guy Miller/Narisha Ragoonanthun 0930
+44 0 20 7469
Corporate Broker 0930
Lucy Williams +44 0 20 7220
Duncan Vasey 9797
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXMZMFMVGFGFZM
(END) Dow Jones Newswires
November 30, 2023 11:14 ET (16:14 GMT)
1 Year Shortwave Life Sciences Chart |
1 Month Shortwave Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
